ethyl 8-(4-ethoxyphenyl)-8-oxooctanoate, 97.0%, 2g

Urea, N-(6,8-difluoro-2-methyl-4-quinolinyl)-N'-[4-(dimethylamino)phenyl]-, 98%, 5mg

Fmoc-4-hydrazinobenzoic acid, 96.0%, 1g

Flacon d'hybridation sans revêtement, Hauteur, 75 mm, 35 mm, 1 Pièce

(2-Fluoro-4-(trifluoromethoxy)phenyl)boronic acid, 95.0%, 100mg

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate, 98%, 25mg

Pentafluorophenyl Benzoate>98.0%(GC)1g

tert-Butyl 4-(1-(4-aminophenyl)piperidine-4-carbonyl)piperazine-1-carboxylate, 250mg

(2-Amino-3-nitrophenyl)methanol, 95%, 1g

(3-(Cyclopropylmethoxy)-5-methylphenyl)boronic acid, 95.0%, 1g

(2S,4S)-4-Hydroxypyrrolidine-2-carboxamide hydrochloride, 98%, 250mg

Ethyl 5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-1H-indole-2-carboxylate, 97%, 100mg

tert-Butyl 7-nitro-3,4-dihydroisoquinoline-2(1H)-carboxylate, 97%, 250mg